期刊论文

He, F.-Y.

中文

中国中药杂志

1001-5302

2013

38

2

253-262

10.4268/cjcmm20130222

国家自然科学基金项目（81073142,30901971） 湖南省自然科学基金重点项目（11JJ2055） 湖南省教育厅“十二五”药学重点学科项目

本校为第一且通讯机构

目的:对已建立的药物动力学总量统计矩法用补阳还五汤中黄芪甲苷、芍药苷、川芎嗪3个成分进行验证,建立中药复方多成分体系的药物动力学实验方法。方法:采用反相高效液相色谱法测定,其条件为C_(18)色谱柱(4.6 mm×250 mm,5μm);黄芪甲苷ELSD测定;流动相乙腈-1%乙酸溶液(35∶65),流速1 mL·min~(-1);柱压(15.0±0.408)MPa;温度30℃;芍药苷、川芎嗪的检测波长254 nm,流动相甲醇-水(33∶67),流速1 mL·min~(-1);柱压(20.71±0.42)MPa。单个成分房室模型药物动力学参数采用DAS软件处理,总量统计矩按公式计算。结果:3个单成分在大鼠体内药物动力学都遵循二室模型(P

OBJECTIVE: To verify established the total quantum statistic moments model with astragaloside IV, paeoniflorin, tetramethylpyrazine in Buyanghuanwu injection, in order to establish a pharmacokinetic experimental method with multi-component traditional Chinese medicine (TCM) compound system. METHOD: The RP-HPLC was adopted, with the chromatographic column of C18, 4.6 mm x 250 mm, 5 microm. As for astragaloside IV, the ELSD detector was adopted with acetonitrile-water (35: 65) as the mobile phase at 1 mL x min(-1); the pressure of column was (15.0 +/- 0.408) MPa, the column temperature was 30 de...